CALLY Index, Frailty and SOFA-2 for Mortality Prediction in Geriatric ICU Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorIstanbul University - Cerrahpasa
About this trial
This study aims to evaluate the prognostic value of the C-reactive protein-albumin-lymphocyte (CALLY) index, Clinical Frailty Scale (CFS), and SOFA-2 score in predicting mortality among geriatric intensive care unit (ICU) patients.
The primary outcome is ICU mortality. Secondary outcomes include 28-day mortality, ICU length of stay, duration of mechanical ventilation, need for renal replacement therapy, and vasopressor requirement.
The study also investigates whether the combined use of these parameters improves predictive performance compared to conventional scoring systems such as APACHE II.
Eligibility criteria
Qualifiers
Age ≥65 years
Admission to the intensive care unit
Availability of required clinical and laboratory data within the first 24 hours of ICU admission
Disqualifiers
Death within the first 24 hours after ICU admission
Missing key clinical or laboratory data
Terminal malignancy receiving palliative care
Trial design
Treatments tested in this trial
- observational study
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Istanbul University - Cerrahpasa
Lead sponsor
Başakşehir Çam & Sakura City Hospital
Sponsor institution
Source ClinicalTrials.gov